Search

Search Constraints

You searched for: Author/Creator Andreas, Karen

Search Results

1. Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild‐Type Non‐Small Cell Lung Cancer. (12th April 2019)